Chloromycetin

Additional information

* Proprietary Ingredient(s) indicated as hazardous have been assessed under standards for workplace safety. 3. HAZARDS IDENTIFICATION Appearance: ointment Signal Word: DANGER Statement of Hazard: May cause cancer. May cause genetic defects. Suspected of damaging fertility or the unborn child. May cause adverse effects on blood forming organs Additional Hazard Information: Short Term: Acute toxicity following ingestion is not expected. Long Term: Repeated or prolonged exposure may cause effects similar to those seen in clinical use. Repeat-dose studies in animals have shown a potential to cause adverse effects on the hematological and reproductive systems. Known Clinical Effects: The most serious adverse reaction seen with the use of chloramphenicol is reversible, dose related, bone marrow depression. Serious and fatal blood effects (aplastic anemia, hypoplastic anemia, thrombocytopenia, and granulocytopenia) have also occurred after chlormaphenicol treatment. The aplastic anemia seen from treatment may terminate in leukemia. GI and CNS effects have occurred infrequently and hypersensitivity reactions have been reported rarely. Ophthalmic use of chloramphenicol has resulted in optic neuritis, impaired central vision, and injury to the optic and peripheral nerves. Prolonged treatment may result in optic neuropathy. Sensitization, manifested as periocular and periauricular dermatitis, has also been reported. EU Indication of danger: T - Toxic EU Hazard Symbols: EU Risk Phrases: R45 - May cause cancer. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.